Kimberly R Pechman

Summary

Affiliation: Medical College of Wisconsin
Country: USA

Publications

  1. pmc Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Research Program, Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Magn Reson Med 68:1266-72. 2012
  2. doi request reprint Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, WI, USA
    J Neurooncol 105:233-9. 2011

Detail Information

Publications2

  1. pmc Evaluation of combined bevacizumab plus irinotecan therapy in brain tumors using magnetic resonance imaging measures of relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Research Program, Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, Wisconsin 53226, USA
    Magn Reson Med 68:1266-72. 2012
    ....
  2. doi request reprint Characterization of bevacizumab dose response relationship in U87 brain tumors using magnetic resonance imaging measures of enhancing tumor volume and relative cerebral blood volume
    Kimberly R Pechman
    Translational Brain Tumor Program, Medical College of Wisconsin, Milwaukee, WI, USA
    J Neurooncol 105:233-9. 2011
    ..Conversely tumor vascularity, as measured with rCBV, was inhibited equally well for all doses used with no clear indication that higher doses are more effective...